Search research articles
Contact Us
Filters
Showing results (281-290 of 367) with videos related to
Page
of 37
Sort By:
Blood
|
September 1, 1989
Predictors of death from chronic graft-versus-host disease after bone marrow transplantation
J R Wingard, S Piantadosi, G B Vogelsang, et al.
The New England Journal of Medicine
|
April 16, 1992
Thalidomide for the treatment of chronic graft-versus-host disease
G B Vogelsang, E R Farmer, A D Hess, et al.
AIDS (London, England)
|
March 1, 1997
Re-evaluation of time to progression of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients clinically resistant to ganciclovir
A J Mueller, M A Jacobson, S Hurwitz, et al.
Ocular Immunology and Inflammation
|
March 14, 2012
Hypotony in patients with uveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial
H Nida Sen, Lea T Drye, Debra A Goldstein, et al.
Ophthalmology
|
October 27, 2015
Cataract Surgery Outcomes in Uveitis: The Multicenter Uveitis Steroid Treatment Trial
H Nida Sen, Francis M Abreu, Thomas A Louis, et al.
American Journal of Ophthalmology
|
July 5, 2023
Cataract Surgery in Patients With Uveitis Treated With Systemic Therapy in the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study: Risk Factors and Outcomes
Douglas A Jabs, Elizabeth A Sugar, Alyce E Burke, et al.
Vascular Pharmacology
|
April 15, 2015
Effect of soluble guanylyl cyclase activator and stimulator therapy on nitroglycerin-induced nitrate tolerance in rats
A Jabs, M Oelze, Y Mikhed, et al.
American Journal of Ophthalmology
|
November 11, 2017
Interobserver Agreement Among Uveitis Experts on Uveitic Diagnoses: The Standardization of Uveitis Nomenclature Experience
Douglas A Jabs, Andrew Dick, John T Doucette, et al.
Ophthalmology
|
June 9, 2014
Cost-effectiveness of fluocinolone acetonide implant versus systemic therapy for noninfectious intermediate, posterior, and panuveitis
, Elizabeth A Sugar, Janet T Holbrook, et al.
Communications Biology
|
March 6, 2021
APOL1 variant alleles associate with reduced risk for opportunistic infections in HIV infection
Ping An, Efe Sezgin, Gregory D Kirk, et al.
Page
of 37
Search research articles
Search
Showing results (281-290 of 367) with videos related to
Sort By:
Page
of 37
Blood
|
September 1, 1989
Predictors of death from chronic graft-versus-host disease after bone marrow transplantation
J R Wingard, S Piantadosi, G B Vogelsang, et al.
The New England Journal of Medicine
|
April 16, 1992
Thalidomide for the treatment of chronic graft-versus-host disease
G B Vogelsang, E R Farmer, A D Hess, et al.
AIDS (London, England)
|
March 1, 1997
Re-evaluation of time to progression of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients clinically resistant to ganciclovir
A J Mueller, M A Jacobson, S Hurwitz, et al.
Ocular Immunology and Inflammation
|
March 14, 2012
Hypotony in patients with uveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial
H Nida Sen, Lea T Drye, Debra A Goldstein, et al.
Ophthalmology
|
October 27, 2015
Cataract Surgery Outcomes in Uveitis: The Multicenter Uveitis Steroid Treatment Trial
H Nida Sen, Francis M Abreu, Thomas A Louis, et al.
American Journal of Ophthalmology
|
July 5, 2023
Cataract Surgery in Patients With Uveitis Treated With Systemic Therapy in the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study: Risk Factors and Outcomes
Douglas A Jabs, Elizabeth A Sugar, Alyce E Burke, et al.
Vascular Pharmacology
|
April 15, 2015
Effect of soluble guanylyl cyclase activator and stimulator therapy on nitroglycerin-induced nitrate tolerance in rats
A Jabs, M Oelze, Y Mikhed, et al.
American Journal of Ophthalmology
|
November 11, 2017
Interobserver Agreement Among Uveitis Experts on Uveitic Diagnoses: The Standardization of Uveitis Nomenclature Experience
Douglas A Jabs, Andrew Dick, John T Doucette, et al.
Ophthalmology
|
June 9, 2014
Cost-effectiveness of fluocinolone acetonide implant versus systemic therapy for noninfectious intermediate, posterior, and panuveitis
, Elizabeth A Sugar, Janet T Holbrook, et al.
Communications Biology
|
March 6, 2021
APOL1 variant alleles associate with reduced risk for opportunistic infections in HIV infection
Ping An, Efe Sezgin, Gregory D Kirk, et al.
Page
of 37